ATA848077A - Verfahren zur herstellung von pharmazeutischen praeparaten - Google Patents

Verfahren zur herstellung von pharmazeutischen praeparaten

Info

Publication number
ATA848077A
ATA848077A AT848077A AT848077A ATA848077A AT A848077 A ATA848077 A AT A848077A AT 848077 A AT848077 A AT 848077A AT 848077 A AT848077 A AT 848077A AT A848077 A ATA848077 A AT A848077A
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
producing pharmaceutical
producing
preparations
pharmaceutical
Prior art date
Application number
AT848077A
Other languages
English (en)
Other versions
AT359197B (de
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of ATA848077A publication Critical patent/ATA848077A/de
Application granted granted Critical
Publication of AT359197B publication Critical patent/AT359197B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT848077A 1976-11-26 1977-11-25 Verfahren zur herstellung von pharmazeutischen praeparaten AT359197B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (2)

Publication Number Publication Date
ATA848077A true ATA848077A (de) 1980-03-15
AT359197B AT359197B (de) 1980-10-27

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT848077A AT359197B (de) 1976-11-26 1977-11-25 Verfahren zur herstellung von pharmazeutischen praeparaten

Country Status (21)

Country Link
JP (1) JPS609697B2 (de)
AR (1) AR218047A1 (de)
AT (1) AT359197B (de)
AU (1) AU511080B2 (de)
BE (1) BE861141A (de)
CA (1) CA1086226A (de)
CH (1) CH639560A5 (de)
DE (1) DE2752728C2 (de)
DK (1) DK150534C (de)
FI (1) FI65910C (de)
FR (1) FR2373288A1 (de)
GB (1) GB1544761A (de)
GR (1) GR61724B (de)
IE (1) IE45998B1 (de)
IL (1) IL53462A (de)
LU (1) LU78584A1 (de)
NL (1) NL182283C (de)
NO (1) NO147626C (de)
NZ (1) NZ185772A (de)
PT (1) PT67323B (de)
SE (1) SE426781B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
AU2018347991A1 (en) 2017-10-09 2020-05-07 Rhodes Pharmaceuticals L.P. Pharmaceutical resinate compositions and methods of making and using thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (de) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
GR61724B (en) 1978-12-29
NZ185772A (en) 1978-12-18
LU78584A1 (de) 1978-04-20
CH639560A5 (en) 1983-11-30
DK150534B (da) 1987-03-23
NL7712996A (nl) 1978-05-30
JPS5369822A (en) 1978-06-21
IL53462A (en) 1980-12-31
JPS609697B2 (ja) 1985-03-12
NL182283C (nl) 1988-02-16
CA1086226A (en) 1980-09-23
DE2752728A1 (de) 1978-06-01
IL53462A0 (en) 1978-01-31
AR218047A1 (es) 1980-05-15
DK523277A (da) 1978-05-27
SE426781B (sv) 1983-02-14
PT67323A (en) 1977-12-01
FI65910B (fi) 1984-04-30
FI65910C (fi) 1984-08-10
NL182283B (nl) 1987-09-16
DK150534C (da) 1987-10-12
BE861141A (fr) 1978-03-16
AT359197B (de) 1980-10-27
NO147626B (no) 1983-02-07
FR2373288B1 (de) 1980-06-13
PT67323B (en) 1979-04-24
IE45998B1 (en) 1983-01-26
SE7713370L (sv) 1978-05-27
NO147626C (no) 1983-05-25
FI773568A (fi) 1978-05-27
AU511080B2 (en) 1980-07-24
IE45998L (en) 1978-05-26
FR2373288A1 (fr) 1978-07-07
DE2752728C2 (de) 1985-08-01
NO774051L (no) 1978-05-29
GB1544761A (en) 1979-04-25
AU3098677A (en) 1979-05-31

Similar Documents

Publication Publication Date Title
LU77562A1 (de) Verfahren zur herstellung von neuen pharmazeutischen praeparaten
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT371709B (de) Verfahren zur herstellung von pharmazeutischen praeparaten in dosiereinheitsform
AT364451B (de) Verfahren zur herstellung von lokalanaesthetisch wirksamen kombinationspraeparaten
AT383271B (de) Verfahren zur herstellung von cerebralwirksamen arzneimitteln
AT363196B (de) Verfahren zur herstellung von androstan-17-on-derivaten
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
AT381025B (de) Verfahren zur herstellung von topischen pharmazeutischen zubereitungen
AT366576B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT354655B (de) Verfahren zur herstellung von neuen peptid- derivaten
AT359197B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT363174B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen
AT353993B (de) Verfahren zur herstellung von neuen peptid- derivaten
ATA803679A (de) Verfahren zur herstellung galenischer zubereitungen
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT366574B (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung
AT343125B (de) Verfahren zur herstellung von 3-phenylpyridazon- (6)
AT378915B (de) Verfahren zur herstellung von antihypertensiven pharmazeutischen zubereitungen
ATA136279A (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT357261B (de) Verfahren zur herstellung von cytostatisch wirkenden arzneimittelpraeparaten
AT355740B (de) Verfahren zur herstellung von neuen peptid- derivaten
DD137057A5 (de) Verfahren zur herstellung von pharmazeutischen zubereitungen zur hemmung der lipogenese
ATA966976A (de) Verfahren zur herstellung von 2-aminoindanderivaten
ATA236577A (de) Verfahren zur herstellung von injektions- praeparaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
EWE Authorization for restitution
ELJ Ceased due to non-payment of the annual fee